Multimodal clinical–imaging deep learning model for predicting refractory hypersplenism after liver transplantation
Open Access
- 22 April 2026
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Abstract
Refractory hypersplenism after liver transplantation (LT), defined in this study as persistent cytopenia and splenomegaly beyond 6 months after LT, is a clinically important postoperative condition. However, reliable methods for preoperative risk stratification remain limited. This study aimed to identify preoperative risk factors and to develop a multimodal deep learning model integrating clinical and CT-derived imaging features for predicting refractory hypersplenism after LT. Patients who underwent LT between 2013 and 2023 were retrospectively analyzed and classified into remission (n = 120) and refractory (n = 44) hypersplenism groups. Clinical, laboratory, and CT-derived splenic parameters were compared. Radiomic features were extracted from preoperative contrast-enhanced CT images. Logistic regression identified independent predictors, and single-modality (clinical or CT) and multimodal (clinical–radiomic) deep learning models were developed. Model performance was evaluated using AUC, F1-score, and accuracy across training, validation, and test cohorts. Preoperative platelet count (OR = 1.04, p = 0.006), splenic length (OR = 0.96, p < 0.001), and splenic vein diameter (OR = 0.81, p = 0.001) were independent predictors. The multimodal model showed the best overall performance (AUC = 0.857, F1 = 0.842), outperforming logistic regression (P = 0.022). Attention maps highlighted the spleen and splenic hilum were among the most influential regions for prediction. Preoperative splenic morphology and imaging features related to splenic hemodynamic burden were associated with refractory hypersplenism after LT. The proposed clinical–radiomic multimodal deep learning model showed promising predictive performance and may provide useful supplementary information for preoperative risk stratification. Further validation in larger multicenter cohorts is needed before broader clinical application.Keywords
Funding Information
- the Clinical Research Incubation Project (No. CYFH20230)
This publication has 24 references indexed in Scilit:
- Selective splenectomy centered on graft-to-spleen volume ratio is a practical option in living donor liver transplantation to prevent early allograft dysfunction: A prospective validation studyLiver Transplantation, 2025
- Splenic Artery Embolization in Living Donor Liver Transplant Recipients: Indications, Safety and Clinical OutcomesJournal of Clinical and Experimental Hepatology, 2025
- Baseline ALBI Grade Predicts Benefits After Splenectomy for Cirrhotic Patients with HypersplenismJournal of Gastrointestinal Surgery, 2023
- Hemodynamic effect through a novel endoscopic intervention in management of varices and hypersplenism (with video)Gastrointestinal Endoscopy, 2022
- Is simultaneous partial splenectomy during pediatric liver transplantation safe and effective for severe hypersplenism? A prospective cohort studyInternational Journal of Surgery, 2021
- Comprehensive Analysis of Long-term Splenic Volume Changes in Pediatric Liver Transplant Patients: Does It Correlate With Adverse Graft Outcomes?Transplantation Proceedings, 2021
- Factors Affecting Persistent Splenomegaly After Adult-to-Adult Living Donor Liver Transplantation Using a Left LobeTransplantation Proceedings, 2019
- Predictive Factors for Persistent Splenomegaly and Hypersplenism After Adult Living Donor Liver TransplantationTransplantation Proceedings, 2012
- Thrombocytopenia, Splenomegaly, and Portal Blood Flow in Patients Who Have Undergone Liver Transplantation for CirrhosisLiver Transplantation, 2011
- Single Administration of Thrombopoietin Prevents Progression of Liver Fibrosis and Promotes Liver Regeneration After Partial Hepatectomy in Cirrhotic RatsAnnals of Surgery, 2008